• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸代谢与卵巢癌:治疗学意义。

Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications.

机构信息

Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Korea.

Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul 02841, Korea.

出版信息

Int J Mol Sci. 2022 Feb 16;23(4):2170. doi: 10.3390/ijms23042170.

DOI:10.3390/ijms23042170
PMID:35216285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8874779/
Abstract

Ovarian cancer is the most malignant gynecological tumor. Previous studies have reported that metabolic alterations resulting from deregulated lipid metabolism promote ovarian cancer aggressiveness. Lipid metabolism involves the oxidation of fatty acids, which leads to energy generation or new lipid metabolite synthesis. The upregulation of fatty acid synthesis and related signaling promote tumor cell proliferation and migration, and, consequently, lead to poor prognosis. Fatty acid-mediated lipid metabolism in the tumor microenvironment (TME) modulates tumor cell immunity by regulating immune cells, including T cells, B cells, macrophages, and natural killer cells, which play essential roles in ovarian cancer cell survival. Here, the types and sources of fatty acids and their interactions with the TME of ovarian cancer have been reviewed. Additionally, this review focuses on the role of fatty acid metabolism in tumor immunity and suggests that fatty acid and related lipid metabolic pathways are potential therapeutic targets for ovarian cancer.

摘要

卵巢癌是最恶性的妇科肿瘤。先前的研究报道称,脂质代谢失调导致的代谢改变促进了卵巢癌的侵袭性。脂质代谢涉及脂肪酸的氧化,这导致能量产生或新的脂质代谢物合成。脂肪酸合成的上调和相关信号的上调促进肿瘤细胞的增殖和迁移,从而导致预后不良。脂肪酸介导的肿瘤微环境(TME)中的脂质代谢通过调节免疫细胞,包括 T 细胞、B 细胞、巨噬细胞和自然杀伤细胞,来调节肿瘤细胞的免疫,这些细胞在卵巢癌细胞的存活中发挥着重要作用。在这里,综述了脂肪酸的类型和来源及其与卵巢癌 TME 的相互作用。此外,本综述还重点讨论了脂肪酸代谢在肿瘤免疫中的作用,并提出脂肪酸和相关脂质代谢途径是卵巢癌潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/831b/8874779/4e23be141291/ijms-23-02170-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/831b/8874779/29fa1e23af17/ijms-23-02170-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/831b/8874779/4e23be141291/ijms-23-02170-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/831b/8874779/29fa1e23af17/ijms-23-02170-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/831b/8874779/4e23be141291/ijms-23-02170-g002.jpg

相似文献

1
Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications.脂肪酸代谢与卵巢癌:治疗学意义。
Int J Mol Sci. 2022 Feb 16;23(4):2170. doi: 10.3390/ijms23042170.
2
Targeting lipid metabolism in the treatment of ovarian cancer.靶向脂质代谢治疗卵巢癌。
Oncotarget. 2022 May 25;13:768-783. doi: 10.18632/oncotarget.28241. eCollection 2022.
3
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.用代谢抑制剂鸡尾酒靶向脂质代谢可根除卵巢癌细胞的腹腔转移。
Commun Biol. 2019 Jul 31;2:281. doi: 10.1038/s42003-019-0508-1. eCollection 2019.
4
Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer.异常脂质代谢:卵巢癌中一个新兴的诊断和治疗靶点。
Int J Mol Sci. 2013 Apr 10;14(4):7742-56. doi: 10.3390/ijms14047742.
5
Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.肝细胞癌细胞中的异常脂质代谢和免疫微环境:综述。
Cell Prolif. 2020 Mar;53(3):e12772. doi: 10.1111/cpr.12772. Epub 2020 Jan 31.
6
Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.白藜芦醇可降低乳酸生成并改变卵巢癌免疫微环境。
Neoplasma. 2022 Sep;69(5):1129-1137. doi: 10.4149/neo_2022_220414N410. Epub 2022 Sep 22.
7
Metabolic cross-talk between ovarian cancer and the tumor microenvironment-providing potential targets for cancer therapy.卵巢癌与肿瘤微环境之间的代谢相互作用——为癌症治疗提供潜在靶点。
Front Biosci (Landmark Ed). 2022 Apr 20;27(4):139. doi: 10.31083/j.fbl2704139.
8
Lipids in the tumor microenvironment: From cancer progression to treatment.肿瘤微环境中的脂质:从癌症进展到治疗。
Prog Lipid Res. 2020 Nov;80:101055. doi: 10.1016/j.plipres.2020.101055. Epub 2020 Aug 11.
9
Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.卵巢癌的代谢重编程涉及 ACSL1 介导的转移刺激,通过上调蛋白质豆蔻酰化。
Oncogene. 2021 Jan;40(1):97-111. doi: 10.1038/s41388-020-01516-4. Epub 2020 Oct 20.
10
New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases.靶向卵巢癌腹膜转移中重新布线的脂质代谢的 Ferroptosis 起始治疗(FIT)的新见解。
Int J Mol Sci. 2022 Dec 3;23(23):15263. doi: 10.3390/ijms232315263.

引用本文的文献

1
Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer.代谢重编程塑造卵巢癌的进展和治疗格局。
Cancer Manag Res. 2025 Aug 19;17:1707-1722. doi: 10.2147/CMAR.S538281. eCollection 2025.
2
Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression.油酸激活转化生长因子β- Smad3信号通路以促进卵巢癌进展。
J Ovarian Res. 2025 Aug 11;18(1):180. doi: 10.1186/s13048-025-01763-7.
3
Fatty Acid Metabolism Regulators Have Pivotal Roles in the Pathogenesis of Ovarian Carcinoma.

本文引用的文献

1
Ovarian cancer: epigenetics, drug resistance, and progression.卵巢癌:表观遗传学、耐药性与进展
Cancer Cell Int. 2021 Aug 17;21(1):434. doi: 10.1186/s12935-021-02136-y.
2
It's not just size that matters: Challenges in studying obesity and female-specific cancers.重要的不只是体型:肥胖与女性特定癌症研究中的挑战。
Lancet Reg Health West Pac. 2021 May 13;11:100164. doi: 10.1016/j.lanwpc.2021.100164. eCollection 2021 Jun.
3
Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
脂肪酸代谢调节因子在卵巢癌发病机制中起关键作用。
Int J Mol Sci. 2025 May 16;26(10):4794. doi: 10.3390/ijms26104794.
4
Organ-specific cancer biomarker identification: a ten-year single-center study in southern China.器官特异性癌症生物标志物的鉴定:中国南方一项为期十年的单中心研究。
BMC Cancer. 2025 May 1;25(1):820. doi: 10.1186/s12885-025-14225-6.
5
The association of dietary fat and fatty acid intake with ovarian cancer survival: findings from the OOPS, a prospective cohort study.膳食脂肪和脂肪酸摄入量与卵巢癌生存率的关联:OOPS前瞻性队列研究的结果
Nutr J. 2025 Apr 30;24(1):70. doi: 10.1186/s12937-025-01135-3.
6
HKDC1 promotes ovarian cancer progression through boosting lipid metabolism and immune escape by stabilizing G6PC/G6PC2.HKDC1通过稳定G6PC/G6PC2促进脂质代谢和免疫逃逸,从而推动卵巢癌进展。
Commun Biol. 2025 Apr 16;8(1):615. doi: 10.1038/s42003-025-08031-w.
7
Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells.大麻二酚可减弱卵巢癌细胞中的脂质代谢,并诱导CB1受体介导的内质网应激相关凋亡。
Sci Rep. 2025 Feb 5;15(1):4307. doi: 10.1038/s41598-025-88917-1.
8
Establishment and verification of a prognostic signature associated with fatty acid metabolism in endometrial cancer.子宫内膜癌中与脂肪酸代谢相关的预后特征的建立与验证
Mol Med Rep. 2025 Mar;31(3). doi: 10.3892/mmr.2025.13444. Epub 2025 Jan 31.
9
Intratumoral microbiota, fatty acid metabolism, and tumor microenvironment constitute an unresolved trinity in colon adenocarcinoma.肿瘤内微生物群、脂肪酸代谢和肿瘤微环境构成了结肠腺癌中一个尚未解决的三元体系。
Sci Rep. 2025 Jan 20;15(1):2568. doi: 10.1038/s41598-025-87194-2.
10
Integrative bioinformatics and machine learning approach unveils potential biomarkers linking coronary atherosclerosis and fatty acid metabolism-associated gene.整合生物信息学和机器学习方法揭示了连接冠状动脉粥样硬化与脂肪酸代谢相关基因的潜在生物标志物。
J Cardiothorac Surg. 2025 Jan 17;20(1):70. doi: 10.1186/s13019-024-03199-4.
O-连接的 N-乙酰氨基葡萄糖转移酶(OGT)和 mTOR 通路对增殖性肝癌细胞脂肪酸合酶(FASN)表达的双重调控。
Cell Mol Life Sci. 2021 Jul;78(13):5397-5413. doi: 10.1007/s00018-021-03857-z. Epub 2021 May 27.
4
Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer.脂质代谢失调:卵巢癌的关键因素
Front Oncol. 2020 Oct 19;10:593017. doi: 10.3389/fonc.2020.593017. eCollection 2020.
5
Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36.脂肪酸样 Pt(IV)前药通过利用 CD36 克服卵巢癌中的顺铂耐药性。
Chem Commun (Camb). 2020 Sep 15;56(73):10706-10709. doi: 10.1039/d0cc02174a.
6
PPAR Beta/Delta and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体-β/δ 与癌症的特征。
Cells. 2020 May 4;9(5):1133. doi: 10.3390/cells9051133.
7
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.脂肪细胞诱导卵巢癌细胞中 FABP4 的表达促进转移并介导卡铂耐药性。
Cancer Res. 2020 Apr 15;80(8):1748-1761. doi: 10.1158/0008-5472.CAN-19-1999. Epub 2020 Feb 13.
8
MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer.MYC 通过 Claudin-low 三阴性乳腺癌中的多基因程序调节脂肪酸代谢。
Br J Cancer. 2020 Mar;122(6):868-884. doi: 10.1038/s41416-019-0711-3. Epub 2020 Jan 16.
9
Reprogramming of fatty acid metabolism in cancer.癌症中脂肪酸代谢的重编程。
Br J Cancer. 2020 Jan;122(1):4-22. doi: 10.1038/s41416-019-0650-z. Epub 2019 Dec 10.
10
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment.IL-17A 通过 IL-17A/IL-17RA/p-STAT3/FABP4 轴促进脂肪酸摄取,为富含脂肪细胞的微环境中的卵巢癌细胞生长提供燃料。
Cancer Immunol Immunother. 2020 Jan;69(1):115-126. doi: 10.1007/s00262-019-02445-2. Epub 2019 Dec 4.